Clinical Trial Update: Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whole brain radiotherapy with or without daily fixed-dose temozolomide for brain metastases; the study is completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Brain Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2013-05-08